APA (7th ed.) Citation

WANG, X., SONG, H., YU, Q., LIU, Q., WANG, L., LIU, Z., & YU, Z. (2015). Ad-p53 enhances the sensitivity of triple-negative breast cancer MDA-MB-468 cells to the EGFR inhibitor gefitinib. Oncology reports, 33(2), 526-532. https://doi.org/10.3892/or.2014.3665

Chicago Style (17th ed.) Citation

WANG, XINZHAO, HONGKUAN SONG, QIAN YU, QI LIU, LEILEI WANG, ZHAOYUN LIU, and ZHIYONG YU. "Ad-p53 Enhances the Sensitivity of Triple-negative Breast Cancer MDA-MB-468 Cells to the EGFR Inhibitor Gefitinib." Oncology Reports 33, no. 2 (2015): 526-532. https://doi.org/10.3892/or.2014.3665.

MLA (9th ed.) Citation

WANG, XINZHAO, et al. "Ad-p53 Enhances the Sensitivity of Triple-negative Breast Cancer MDA-MB-468 Cells to the EGFR Inhibitor Gefitinib." Oncology Reports, vol. 33, no. 2, 2015, pp. 526-532, https://doi.org/10.3892/or.2014.3665.